Early changes in serum IL-1RA were associated with response to ICB in patients with metastatic ESCC or CRC, and early changes in BDNF levels were associated with response to ICB in patients with GC (eFigure 6 in the Supplement). This evidence concerns the gene BDNF and colorectal carcinoma.